| Cdp Health Care System-browns Valley Clinic | |
|
404 West Broadway Browns Valley MN 56219 | |
| (320) 695-2526 | |
| (320) 695-2106 |
| Full Name | Cdp Health Care System-browns Valley Clinic |
|---|---|
| Speciality | Clinic/Center |
| Location | 404 West Broadway, Browns Valley, Minnesota |
| Authorized Official Name and Position | Greg A. Weaver (INTERIM CEO) |
| Authorized Official Contact | 6056987647 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Cdp Health Care System-browns Valley Clinic 205 Orchard Dr Sisseton SD 57262-2398 Ph: (605) 698-7681 | Cdp Health Care System-browns Valley Clinic 404 West Broadway Browns Valley MN 56219 Ph: (320) 695-2526 |
| NPI Number | 1255477162 |
|---|---|
| Provider Enumeration Date | 01/29/2007 |
| Last Update Date | 08/27/2018 |
| Medicare PECOS PAC ID | 8022926468 |
|---|---|
| Medicare Enrollment ID | O20080401000657 |
News Archive
Major reforms are needed in the nation's immigration court and detention system to ensure fair treatment and due process for immigrants with mental disabilities, according to new findings released today by Texas Appleseed, with pro bono counsel Akin Gump Strauss Hauer & Feld LLP.
The nursing textbook, Policy & Politics in Nursing and Health Care, 6th Edition has received high honors and reviews. Society for Women's Health Research (SWHR) Board member and leader in women's and infants' health and research, Irma Goertzen, RN, MA authored a chapter in this must-have textbook.
Inside the Mizzou Asphalt Pavement and Innovation Lab at the University of Missouri College of Engineering, Bill Buttlar normally leads a research team developing innovative ways to build better roads and stronger bridges.
This week, Lancet Oncology reports results of a 1,093-person phase III clinical trial of the drug necitumumab (IMC-11F8) combined with chemotherapies gemcitabine and cisplatin against stage IV squamous non-small cell lung cancer. With addition of necitumumab, median overall survival was 11.5 months compared with median survival of 9.9 months with the two chemotherapies alone.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255477162 | NPI | - | NPPES |
| 5160 | Medicaid | ND | |
| 49082CO | Other | MN | BLUE CROSS |
| 03070116200 | Other | PRIMEWEST | |
| 05160 | Medicaid | ND |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | 60020 (South Dakota) | Primary |
| 261QR1300X | Clinic/center - Rural Health | 60020 (South Dakota) | Secondary |
| Provider Name | Stanley C Gallagher |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1831125657 PECOS PAC ID: 4385552504 Enrollment ID: I20060320000295 |
News Archive
Major reforms are needed in the nation's immigration court and detention system to ensure fair treatment and due process for immigrants with mental disabilities, according to new findings released today by Texas Appleseed, with pro bono counsel Akin Gump Strauss Hauer & Feld LLP.
The nursing textbook, Policy & Politics in Nursing and Health Care, 6th Edition has received high honors and reviews. Society for Women's Health Research (SWHR) Board member and leader in women's and infants' health and research, Irma Goertzen, RN, MA authored a chapter in this must-have textbook.
Inside the Mizzou Asphalt Pavement and Innovation Lab at the University of Missouri College of Engineering, Bill Buttlar normally leads a research team developing innovative ways to build better roads and stronger bridges.
This week, Lancet Oncology reports results of a 1,093-person phase III clinical trial of the drug necitumumab (IMC-11F8) combined with chemotherapies gemcitabine and cisplatin against stage IV squamous non-small cell lung cancer. With addition of necitumumab, median overall survival was 11.5 months compared with median survival of 9.9 months with the two chemotherapies alone.
› Verified 9 days ago
| Provider Name | Angela K Gaikowski |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1275788960 PECOS PAC ID: 9032339510 Enrollment ID: I20141126000055 |
News Archive
Major reforms are needed in the nation's immigration court and detention system to ensure fair treatment and due process for immigrants with mental disabilities, according to new findings released today by Texas Appleseed, with pro bono counsel Akin Gump Strauss Hauer & Feld LLP.
The nursing textbook, Policy & Politics in Nursing and Health Care, 6th Edition has received high honors and reviews. Society for Women's Health Research (SWHR) Board member and leader in women's and infants' health and research, Irma Goertzen, RN, MA authored a chapter in this must-have textbook.
Inside the Mizzou Asphalt Pavement and Innovation Lab at the University of Missouri College of Engineering, Bill Buttlar normally leads a research team developing innovative ways to build better roads and stronger bridges.
This week, Lancet Oncology reports results of a 1,093-person phase III clinical trial of the drug necitumumab (IMC-11F8) combined with chemotherapies gemcitabine and cisplatin against stage IV squamous non-small cell lung cancer. With addition of necitumumab, median overall survival was 11.5 months compared with median survival of 9.9 months with the two chemotherapies alone.
› Verified 9 days ago
News Archive
Major reforms are needed in the nation's immigration court and detention system to ensure fair treatment and due process for immigrants with mental disabilities, according to new findings released today by Texas Appleseed, with pro bono counsel Akin Gump Strauss Hauer & Feld LLP.
The nursing textbook, Policy & Politics in Nursing and Health Care, 6th Edition has received high honors and reviews. Society for Women's Health Research (SWHR) Board member and leader in women's and infants' health and research, Irma Goertzen, RN, MA authored a chapter in this must-have textbook.
Inside the Mizzou Asphalt Pavement and Innovation Lab at the University of Missouri College of Engineering, Bill Buttlar normally leads a research team developing innovative ways to build better roads and stronger bridges.
This week, Lancet Oncology reports results of a 1,093-person phase III clinical trial of the drug necitumumab (IMC-11F8) combined with chemotherapies gemcitabine and cisplatin against stage IV squamous non-small cell lung cancer. With addition of necitumumab, median overall survival was 11.5 months compared with median survival of 9.9 months with the two chemotherapies alone.
› Verified 9 days ago